Help your patients make the move to APRISO by requesting samples today. After you have submitted the form below, a Salix representative will contact you about your request.
Thank you for visiting . By clicking OK you will be taken to
Pharmaceuticals does not possess editorial control over the content of the information
provided in such website(s) and therefore does not warrant their accuracy and completeness.
You are solely responsible for interactions with such website(s).
You are now entering a site that is for US healthcare professionals only. By selecting I Confirm below, you certify that you are a US healthcare professional and wish to proceed to this section of the site. Products or treatments described on this site are available in the United States but may not be available in all other countries.
I certify that I am a licensed US healthcare professional and wish to proceed to the healthcare professional section of this site.
APRISO® (mesalamine) extended-release capsules are indicated for the maintenance of remission of ulcerative colitis (UC) in patients 18 years of age and older.
To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals at 1-800-508-0024 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information for APRISO extended-release capsules.
For product information, adverse event reports, and product complaint reports, please contact:
Salix Product Information Call Center